One of America’s leading universities, New York University (NYU), will utilise Kiwi MoleMap technology to advance skin cancer research and help find new ways to detect melanoma earlier.

A spokesman for MoleMap told NBR the deal was worth $500,000 a year.

The Charles C. Harris Skin and Cancer Unit, a teaching hospital at NYU’s Langone Medical Center will now have access to 1000’s of Kiwi and Australian melanoma case studies for their residents and researchers to examine.